Methotrexate Elimination in a Patient with an Orthotopic Neobladder with and without a Urethral Catheter
Authors:
- Robert E. DupuisRDRobert E. Dupuis
- James L. MohlerJMJames L. Mohler
- Stephen A. BernardSBStephen A. Bernard
- Celeste M. LindleyCLCeleste M. Lindley
- 10 September 1996
- journal article
- case report
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 16 (5) , 961-964
Abstract
Placement of a urethral catheter has been recommended to ensure adequate methotrexate elimination in patients with a neobladder; however, the need for this and its impact on methotrexate elimination have not been determined. A 53‐year‐old man with a cecal continent urinary diversion received intravenous methotrexate 30 mg/m2 on two occasions, with and without urethral catheter drainage of the neobladder. Serum methotrexate concentrations declined at a rate that resulted in 24‐ and 48‐hour values falling below the accepted toxic concentration threshold of 5–50 μmol/L and 0.05 μmol/L, respectively. In this man, who received low‐dose methotrexate, catheterization of the neobladder did not alter methotrexate elimination sufficiently to justify its cost, risk, and inconvenience.Keywords
This publication has 10 references indexed in Scilit:
- The insertion and management of indwelling urethral catheters—minimizing the risk of infectionJournal of Hospital Infection, 1993
- Catheter-associated urinary tract infections: Epidemiology, pathogenesis, and preventionThe American Journal of Medicine, 1991
- The Catheter and Urinary Tract InfectionMedical Clinics of North America, 1991
- Unexpectedly High Serum Methotrexate Levels in Cystectomized Bladder Cancer Patients with an Ileal Conduit Treated with Intermediate Doses of the DrugJournal of Urology, 1990
- Absorption of Drugs from Continent Caecal Reservoir for UrineBritish Journal of Urology, 1989
- M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Transitional Cell Carcinoma of the UrotheliumJournal of Urology, 1988
- Methotrexate Toxicity Associated with an IIeal ConduitBritish Journal of Urology, 1987
- Functional and structural studies of ileal reservoirs used for continent urostomy and ileostomy.Gut, 1983
- Pharmacokinetic monitoring of high-dose methotrexateCancer Chemotherapy and Pharmacology, 1979
- High dose methotrexate therapy of solid tumors: observations relating to clinical toxicityMedical and Pediatric Oncology, 1976